171 related articles for article (PubMed ID: 9331880)
1. No desensitization of the growth hormone (GH) response between GH-releasing peptide-2 and GH-releasing factor in calves.
Roh SG; He ML; Matsunaga N; Hidaka S; Hidari H
J Anim Sci; 1997 Oct; 75(10):2749-53. PubMed ID: 9331880
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves.
Roh SG; Matsunaga N; Hidaka S; Hidari H
Endocr J; 1996 Jun; 43(3):291-8. PubMed ID: 8886623
[TBL] [Abstract][Full Text] [Related]
3. Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone.
Robinson BM; Friberg RD; Bowers CY; Barkan AL
J Clin Endocrinol Metab; 1992 Oct; 75(4):1121-4. PubMed ID: 1400881
[TBL] [Abstract][Full Text] [Related]
4. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture.
Cheng K; Chan WW; Barreto A; Convey EM; Smith RG
Endocrinology; 1989 Jun; 124(6):2791-8. PubMed ID: 2541999
[TBL] [Abstract][Full Text] [Related]
5. The effects of growth hormone-releasing peptide-2 (GHRP-2) on the release of growth hormone and growth performance in swine.
Phung LT; Inoue H; Nou V; Lee HG; Vega RA; Matsunaga N; Hidaka S; Kuwayama H; Hidari H
Domest Anim Endocrinol; 2000 Apr; 18(3):279-91. PubMed ID: 10793268
[TBL] [Abstract][Full Text] [Related]
6. Effects of the administration of growth hormone-releasing peptide-2 (GHRP-2) orally by gavage and in feed on growth hormone release in swine.
Phung LT; Sasaki A; Lee HG; Vega RA; Matsunaga N; Hidaka S; Kuwayama H; Hidari H
Domest Anim Endocrinol; 2001 Jan; 20(1):9-19. PubMed ID: 11164330
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of growth hormone-releasing peptide-2 in bovine pituitary cells.
Roh SG; He ML; Matsunaga N; Hidaka S; Hidari H
J Anim Sci; 1997 Oct; 75(10):2744-8. PubMed ID: 9331879
[TBL] [Abstract][Full Text] [Related]
8. Intranasal administration of His-D-Trp-Ala-Trp-D-Phe-LysNH2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-I levels in normal men.
Hayashi S; Okimura Y; Yagi H; Uchiyama T; Takeshima Y; Shakutsui S; Oohashi S; Bowers CY; Chihara K
Endocrinol Jpn; 1991 Feb; 38(1):15-21. PubMed ID: 1915110
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
[TBL] [Abstract][Full Text] [Related]
10. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action.
Fairhall KM; Mynett A; Robinson IC
J Endocrinol; 1995 Mar; 144(3):555-60. PubMed ID: 7738479
[TBL] [Abstract][Full Text] [Related]
11. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
Bowers CY; Granda-Ayala R
Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone.
Bowers CY; Reynolds GA; Durham D; Barrera CM; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1990 Apr; 70(4):975-82. PubMed ID: 2108187
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men.
Hartman ML; Farello G; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1992 Jun; 74(6):1378-84. PubMed ID: 1592884
[TBL] [Abstract][Full Text] [Related]
15. The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats.
Badger TM; Millard WJ; McCormick GF; Bowers CY; Martin JB
Endocrinology; 1984 Oct; 115(4):1432-8. PubMed ID: 6148232
[TBL] [Abstract][Full Text] [Related]
16. Oral activity of the growth hormone releasing peptide His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in rats, dogs and monkeys.
Walker RF; Codd EE; Barone FC; Nelson AH; Goodwin T; Campbell SA
Life Sci; 1990; 47(1):29-36. PubMed ID: 2117689
[TBL] [Abstract][Full Text] [Related]
17. GH responses to intravenous bolus infusions of GH releasing hormone and GH releasing peptide 2 separately and in combination in adult volunteers.
Tiulpakov AN; Brook CG; Pringle PJ; Peterkova VA; Volevodz NN; Bowers CY
Clin Endocrinol (Oxf); 1995 Sep; 43(3):347-50. PubMed ID: 7586605
[TBL] [Abstract][Full Text] [Related]
18. The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.
Wu D; Chen C; Zhang J; Bowers CY; Clarke IJ
J Endocrinol; 1996 Feb; 148(2):197-205. PubMed ID: 8699133
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation.
DeBell WK; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1991 Jun; 72(6):1312-6. PubMed ID: 2026752
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats.
Yagi H; Kaji H; Sato M; Okimura Y; Chihara K
Neuroendocrinology; 1996 Feb; 63(2):198-206. PubMed ID: 9053785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
